TEVA:NYE-Teva Pharma Industries Ltd ADR (USD)

COMMON STOCK | Drug Manufacturers - Specialty & Generic |

Last Closing

USD 16.93

Change

0.00 (0.00)%

Market Cap

N/A

Volume

0.02B

Analyst Target

USD 12.19
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-11 )

Largest Industry Peers for Drug Manufacturers - Specialty & Generic

Symbol Name Price(Change) Market Cap
ZTS Zoetis Inc

N/A

USD 66.32B
HLN Haleon plc

N/A

USD 45.41B
TAK Takeda Pharmaceutical Co Ltd A..

N/A

USD 43.84B
RDY Dr. Reddy’s Laboratories Ltd..

N/A

USD 11.39B
ELAN Elanco Animal Health

N/A

USD 4.28B
AMRX Amneal Pharmaceuticals, Inc. C..

N/A

USD 3.25B
BHC Bausch Health Companies Inc

N/A

USD 1.60B
CPHI China Pharma Holdings Inc

N/A

USD 4.61M
YCBD cbdMD Inc

N/A

USD 1.44M
EBS Emergent Biosolutions Inc

N/A

N/A

ETFs Containing TEVA

FLWR:SW 5.80 % 0.00 %

N/A

N/A
ISRPF iShares Public Limited Co.. 5.39 % 0.00 %

N/A

USD 2.22B
ALFI 0.00 % 0.88 %

N/A

N/A
EIS iShares MSCI Israel ETF 0.00 % 0.59 %

N/A

N/A
GNRX 0.00 % 0.55 %

N/A

N/A
GWL 0.00 % 0.34 %

N/A

N/A
ISRA VanEck Israel ETF 0.00 % 0.60 %

N/A

USD 0.09B
ISRL:LSE 0.00 % 0.00 %

N/A

N/A
TASE:LSE 0.00 % 0.00 %

N/A

N/A
IS3T:F iShares IV Public Limited.. 0.00 % 0.00 %

N/A

N/A
IS3T:XETRA iShares MSCI World Size F.. 0.00 % 0.00 %

N/A

N/A
ISRCF iShares V Public Limited .. 0.00 % 0.00 %

N/A

N/A
ISRHF iShares V Public Limited .. 0.00 % 0.00 %

N/A

N/A
ISRUF iShares V Public Limited .. 0.00 % 0.00 %

N/A

N/A
ISRZF iShares II Public Limited.. 0.00 % 0.00 %

N/A

N/A
ISRIF 0.00 % 0.00 %

N/A

N/A
ISRVF iShares Public Limited Co.. 0.00 % 0.00 %

N/A

N/A
ISRWF iShares II Public Limited.. 0.00 % 0.00 %

N/A

N/A
ISRNF 0.00 % 0.00 %

N/A

N/A
ISRRF 0.00 % 0.00 %

N/A

N/A
FLWG:LSE 0.00 % 0.00 %

N/A

N/A
FLWR:LSE 0.00 % 0.00 %

N/A

N/A
BLUM:XETRA 0.00 % 0.00 %

N/A

N/A
BLUM:F 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Drug Manufacturers - Specialty & Generic) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -23.19% 21% F 10% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -23.19% 21% F 9% A-
Trailing 12 Months  
Capital Gain 4.18% 50% F 62% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 4.18% 50% F 50% F
Trailing 5 Years  
Capital Gain 48.25% 85% B 54% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 48.25% 69% C- 44% F
Average Annual (5 Year Horizon)  
Capital Gain 13.26% 73% C 76% C+
Dividend Return 13.26% 73% C 72% C
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 42.79% 40% F 19% F
Risk Adjusted Return 30.98% 73% C 48% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector